Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Longitudinal investigation of the vaginal microbiota and its association with mucosal immune activation following human immunodeficiency virus vaccine vector administration

FY 2018-19

Summary
Women are especially at high risk of Human immunodeficiency virus (HIV) acquisition due to the dynamic nature of the female genital tract (FGT). Bacterial Vaginosis (BV) is a microbial imbalance of the FGT characterized by a shift from a Lactobacillus dominant state to a diverse community of Gram negative anaerobic bacteria and has been linked to increased susceptibility to HIV. Studies suggest a positive association exists between BV and inflammation in the FGT, although the mechanisms by which BV may increase HIV risk are unclear. We conducted a 48 week trial to assess the safety of the shingles live attenuated vaccine as a potential HIV vaccine vector. Kenyan women at low risk to HIV were sampled monthly for cervicovaginal cytokine, HIV target cell levels(immune activation markers), and vaginal microbiota. I characterized the cervicovaginal microbiome data in our study to discover five microbial communities; three dominated by Lactobacillus species, and two BV associated groups. Goal:To determine whether a consistent temporal association exists between specific vaginal microbial communities, immune activation and pro- and anti-inflammatory cytokine levels in the FGT. Hypothesis:Cervicovaginal microbial communities with high abundances of BV associated bacteria will consistently associate with increased cervical pro-inflammatory cytokine levels and increasing levels of HIV target cells. Methods:Cytokine and immune activation levels will be compared to FGT microbial communities longitudinally with both inter and intra-individual comparisons. Non parametric statistical analysis will be performed. Impact:This study will further understanding on how BV may temporally associate with increased susceptibility to HIV risk, and is the first of its kind in a low risk group.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406354
Name
Shvartsman Elinor
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Longitudinal investigation of the vaginal microbiota and its association with mucosal immune activation following human immunodeficiency virus vaccine vector administration
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cpn60; Dmpa; Hiv Prevention; Immune Activation; Inflammation; Kavi-Vzv001 Cohort; Longitudinal; Vaccine; Vaginal Microbiome; Women
Abstract
Women are especially at high risk of Human immunodeficiency virus (HIV) acquisition due to the dynamic nature of the female genital tract (FGT). Bacterial Vaginosis (BV) is a microbial imbalance of the FGT characterized by a shift from a Lactobacillus dominant state to a diverse community of Gram negative anaerobic bacteria and has been linked to increased susceptibility to HIV. Studies suggest a positive association exists between BV and inflammation in the FGT, although the mechanisms by which BV may increase HIV risk are unclear. We conducted a 48 week trial to assess the safety of the shingles live attenuated vaccine as a potential HIV vaccine vector. Kenyan women at low risk to HIV were sampled monthly for cervicovaginal cytokine, HIV target cell levels(immune activation markers), and vaginal microbiota. I characterized the cervicovaginal microbiome data in our study to discover five microbial communities; three dominated by Lactobacillus species, and two BV associated groups. Goal:To determine whether a consistent temporal association exists between specific vaginal microbial communities, immune activation and pro- and anti-inflammatory cytokine levels in the FGT. Hypothesis:Cervicovaginal microbial communities with high abundances of BV associated bacteria will consistently associate with increased cervical pro-inflammatory cytokine levels and increasing levels of HIV target cells. Methods:Cytokine and immune activation levels will be compared to FGT microbial communities longitudinally with both inter and intra-individual comparisons. Non parametric statistical analysis will be performed. Impact:This study will further understanding on how BV may temporally associate with increased susceptibility to HIV risk, and is the first of its kind in a low risk group.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shvartsman, Elinor
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~